Q3 2021 Orexo AB Earnings Call Transcript
Welcome to the Orexo's Q3 report for 2021. (Operator Instructions) Today, I am pleased to present our first speaker, CEO, Nikolaj Sorensen. Please begin your meeting.
¸ - ()-&
Thank you very much, and welcome to this third quarter presentation for Orexo. Some of you will notice, we've been following us for a while, and we have chosen a new format for our presentation, and I hope it's something that you will appreciate. I will start on Page #2 with the agenda. So I will talk a little about the key achievements during the third quarter. Then we -- I will continue talking about the U.S. pharma progress. But I know based on the number of questions we have received prior to the call during the morning, but there's a lot of focus on because of therapeutics. So we have invited Dennis Urbaniak, who will join us from Chicago, where we have a kickoff meeting with part of our feed force or the sales of modia. And Dennis, as you know, he is responsible for digital
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |